Combined Treatment for Generalized Anxiety Disorder (GAD)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a preliminary evaluation of the efficacy of combined
medication and psychotherapy for generalized anxiety disorder (GAD). The general goals of the
current study are to conduct a late stage treatment development study. The goal of this stage
of research is to provide a preliminary answer to the question and to gather data to estimate
intervention parameters (e.g., effect size, attrition rates, response rates) that would
assist in planning further research.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
National Institute of Mental Health (NIMH) National Institutes of Health (NIH)